Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Revix Plus is a multi-ingredient nutritional supplement and antioxidant complex developed and marketed by Renomed Lifesciences. Formulated as an oral softgel capsule, it contains a combination of vitamins, minerals, and antioxidants, including benfotiamine, methylcobalamin, alpha-lipoic acid, inositol, folic acid, chromium, and selenium dioxide. The supplement is primarily indicated for the treatment of nutritional deficiencies and supports physiological processes such as the formation of red blood cells, enhancement of iron absorption, and improvement of hemoglobin levels to reduce the risk of anemia. Additionally, its antioxidant components, such as alpha-lipoic acid and selenium, help protect the body from oxidative stress and damage caused by free radicals. It is currently marketed as an approved product in India.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Revix Plus.